Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

Michael O'Riordan

June 26, 2018

Presentation The Structural Heart Disease Summit 2018

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

Presenter: Vinod H. Thourani, John G. Webb, David A. Wood

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Presenter: Axel Linke, Vinod H. Thourani, Jeffrey J. Popma

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Presenter: Alexander Lauten

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Presenter: Michael J. Mack

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Presenter: Howard C. Herrmann, Fabian Nietlispach, Cenap Undemir, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Video

SHDS 2018: Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

June 26, 2018

Advertisement

Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli

The Vancouver Minimalist Clinical Care Pathway: Updates from the 3M Trial and Evolution to BENCHMARK

Program Update: The Evolut R/PRO TAVR System: Design Characteristics, Clinical Data, and Future Vision

Evolution of Caval Valves (CAVI)Last Resort TR Patients: Technology and Clinical Updates

Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Early Degeneration of First Generation Sapien Valve Treated With Valve-in-Valve Evolut R Valve

Evolut R Low-Risk

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

SHDS 2018: Refining the Innovation Process in the US: Evolution to an Early Feasibility Study (EFS) Network

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content